Cyclooxygenase-2 expression in gastrointestinal stromal tumours

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 4, 2010, Pages 849-853

  Sevinc, Alper ^a   Camci, Celalettin ^a   Sari, Ibrahim ^a   Kalender, Mehmet Emin ^a   Er, Ozlem ^b   Soyuer, Isin ^a   Dikilitas, Mustafa ^b   Yilmaz, Ugur ^c   Sagol, Ozgur ^c   Alacacioglu, Ahmet ^c  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

COX 2; GIST; Immunohistochemical staining; Mitosis rate; Prognosis

Indexed keywords

EID: 78650689699     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Asano T, Shoda J, Ueda T, et al (2002). Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression. Clin Cancer Res, 8, 1157-67.
2. Demetri GD, von Mehren M, Blanke CD, et al (1998). Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med, 347, 472-80.
3. Fujita T, Matsui M, Takaku K, et al (). Size-and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res, 58, 4823-6.
4. Gumurdulu D, Erdogan S, Kayaselcuk F, et al (2007). Expression of COX-2, PCNA, Ki-67 and p53 in gastrointestinal stromal tumors and its relationship with histopathological parameters. World J Gastroenterol, 13, 426-31.
5. Miettinen M, Lasota J (2001). Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch, 438, 1-12.
6. Sano H, Kawahito Y, Wilder RL, et al (1995). Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res, 55, 3785-9.
7. Sevinc A, Camci C, Yilmaz M, et al (2007). The diagnosis of C-kit negative GIST by PDGFRA staining: clinical, pathological, and nuclear medicine perspective. Onkologie, 30, 645-8.
8. Sevinc A, Turhal NS (2008). Please, desist RECIST criteria in GIST, at least in me. Onkologie, 31, 556.
9. Sevinc A, Camci C (2009). 'Times is a GIFT in GIST' - The medical and paramedical perspective of a case with metastatic gastrointestinal stromal tumor. Chemotherapy, 55, 11-14.
10. Sheehan KM, Sabah M, Cummins RJ, et al (2003). Cyclooxygenase-2 expression in stromal tumors of the gastrointestinal tract. Hum Pathol, 34, 1242-6.
11. Siberman S, Joensuu H (2002). Overview of issues related to imatinib therapy of advanced gastrointestinal stromal tumors: a discussion among the experts. Eur J Cancer, 38, 66-9.
12. Stepanova E, et al (2005). ASCO Annual Meeting Proceedings. 23, 9703.
13. Stewart AE, Heslin MH, Arch J, et al (2006). Cyclooxygenase-2 expression and clinical outcome in gastrointestinal stromal tumors. J Gastrointest Surg, 10, 315-9.
14. Tsujii M, Kawano S, DuBois RN (1997). Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA, 94, 3336-40.